Agios Pharmaceuticals Inc., of Cambridge, Mass., appointed Jonathan Biller chief legal officer, effective Dec. 3.
Aligos Therapeutics Inc., of South San Francisco, appointed Kathleen Sereda Glaub to its board.
Arrakis Therapeutics Inc., of Waltham, Mass, appointed Katrine Bosley chair of its board.
Arvinas Inc., of New Haven, Conn., appointed Laurie Smaldone Alsup to its board.
Biodelivery Sciences International Inc., of Raleigh, N.C., appointed Vanila M. Singh to its board.
Cerevel Therapeutics LLC, of Boston, appointed Bryan K. Phillips chief legal officer.
Cure Pharmaceutical Inc., of Oxnard, Calif., appointed John K. Bell to its board.
Mannkind Corp., of Westlake Village, Calif., appointed Anthony Hooper to its board, effective Jan. 1, 2020.
Progenics Pharmaceuticals Inc., of New York, appointed David W. Mims interim CEO.